Vimta Labs Ltd

Vimta Labs Merger & Restructuring Worth ₹0.08 Cr

Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.

Value

₹0.08 Cr

Vimta Labs Earnings Call Transcript: Key Takeaways

Stable Q2 performance masked by R&D lulls and logistics headwinds.

Call

Guides 25% growth

Vimta Labs Results Update

Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.

Vimta Labs Investor Presentation: Key Takeaways

Q2 FY27: total income Rs1,149Mn (+9.9% YoY), EBITDA Rs408Mn (35.5% margin), PAT Rs206Mn (17.9% margin, +3.5% YoY). H1 FY27 PAT Rs417Mn (+7.3%).

Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY

Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.

Key figure

Net profit ₹20.6 Cr · +3.5% YoY

Vimta Labs Board Meeting Date

Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.

Vimta Labs Other Announcement

Vimta Labs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.